Anti-angiogenesis therapy for the treatment of breast cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61P 35/04 (2006.01)

Patent

CA 2744158

This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human subjects susceptible to or diagnosed with breast cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti- tumor therapeutic agents.

La présente invention concerne généralement le traitement de maladies et d'états pathologiques avec des anticorps anti-VEGF. Plus spécifiquement, l'invention concerne le traitement de sujets humains susceptibles de développer ou diagnostiqués avec un cancer du sein en utilisant un anticorps anti-VEGF, de préférence en combinaison avec un ou plusieurs agents thérapeutiques anticancéreux additionnels.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-angiogenesis therapy for the treatment of breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-angiogenesis therapy for the treatment of breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-angiogenesis therapy for the treatment of breast cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2019994

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.